Related Experiment Video
Updated: Aug 16, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Improvement in long-term prognosis by coronary bypass surgery in patients with 3-vessel coronary disease--a matched
1Department of Cardiology, Ashikaga Red Cross Hospital, Tochigi-ken, Japan.
Insights
Surgical treatment for three-vessel coronary artery disease showed improved survival and fewer ischemic events compared to medical management. This study highlights the benefits of surgical intervention for patients with significant coronary artery disease.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Clinical Medicine
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Optimal treatment strategies for patients with significant three-vessel disease are continually being evaluated.
- Matching patient characteristics is crucial for comparing medical versus surgical interventions.
Purpose of the Study:
- To compare long-term survival and ischemic event rates between medically and surgically treated patients with three-vessel coronary artery disease.
- To evaluate the efficacy of surgical revascularization versus medical management in a matched cohort.
Main Methods:
- A comparative study of 61 medically treated and 78 surgically treated patients at a Japanese community hospital.
- Patients were matched for significant three-vessel disease, ejection fraction >40%, bypassable left anterior descending artery, sex, and age.
- Survival and ischemic event rates (non-fatal myocardial infarction, primary cardiac death) were analyzed using Cox-Mantel analysis.
Main Results:
- Surgically treated patients demonstrated significantly better 5- and 9-year survival rates (93% and 85%) compared to medically treated patients (74% and 55%; p < 0.01).
- Rates of absence of ischemic events at 5 and 9 years were superior in the surgical group (92% and 87%) versus the medical group (66% and 52%; p < 0.001).
- Perioperative mortality in the surgical group was low (5 deaths), with few late cardiac events, while the medical group experienced higher cardiac mortality and non-fatal infarctions.
Conclusions:
- Surgical treatment, utilizing saphenous vein grafts, offers a survival advantage for patients with three-vessel coronary artery disease compared to medical management.
- The study suggests that surgical intervention is associated with a reduced incidence of major adverse cardiac events in this patient population.
- Despite being a non-randomized study, the findings indicate a significant benefit of surgical treatment for selected patients with complex coronary artery disease.
Abstract:
We compared survival patterns in 61 medically treated and 78 surgically treated patients at a Japanese community hospital. The 2 groups were matched for presence of significant 3 vessel disease, resting ejection fraction of more than 40%, a bypassable left anterior descending artery, sex, and age. All surgical patients received saphenous vein grafts. The patients treated surgically had better 5 and 9 years survival rates than the medically treated patients (93% and 85% vs 74% and 55%, respectively; p < 0.01 by Cox-Mantel analysis). Five and 9 years rates of absence of ischemic events (non-fatal myocardial infarction and primary cardiac death) were also better in the surgical group than the medical group (92% and 87% vs 66% and 52%, respectively; p < 0.001). Of the surgically treated patients, 5 died perioperatively, 3 had late cardiac deaths and 2 had a nonfatal infarction. Among the medically treated patients, 16 had cardiac deaths, and 6 had non-fatal infarctions. Although our study was non-randomized, we have shown an advantage for surgical treatment of patients with 3-vessel coronary disease.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management